Exosomal LMP1 activates the PI3K/AKT pathway, and then up-regulates the expression of the surface marker CD44+/High, ultimately increasing the populations of CD44+/High cells, which are the putative stem cell in nasopharyngeal carcinoma cells [150–152]. The gene discussed is CD44; the disease is nasopharyngeal carcinoma.